Tobin Gerard, Thunberg Ulf, Karlsson Karin, Murray Fiona, Laurell Anna, Willander Kerstin, Enblad Gunilla, Merup Mats, Vilpo Juhani, Juliusson Gunnar, Sundström Christer, Söderberg Ola, Roos Göran, Rosenquist Richard
Dept of Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Blood. 2004 Nov 1;104(9):2879-85. doi: 10.1182/blood-2004-01-0132. Epub 2004 Jun 24.
We recently identified a chronic lymphocytic leukemia (CLL) subgroup using the immunoglobulin variable heavy-chain (V(H)) gene V(H)3-21 with almost identical heavy-chain complementarity determining region 3s (HCDR3s) and preferential variable light-chain (V(L)) gene usage, suggesting recognition of a common antigen epitope in this subset. To further explore the B-cell receptors (BCRs) in CLL, we characterized 407 V(H) rearrangements amplified from 346 CLLs regarding V(H), diversity (D), and joining (J(H)) gene usage and performed multiple alignment of the HCDR3 sequences. These analyses revealed 3 small subsets (2 V(H)1-69 groups, 7 cases; and 1 V(H)1-2 group, 5 cases) with highly restricted HCDR3 features including identical V(H)/D/J(H) usage, HCDR3 lengths, and shared N-sequences, in addition to the V(H)3-21 group (22 cases). Furthermore, another 3 groups (9 V(H)1-3(+) cases, 3 V(H)1-18(+) cases, and 5 V(H)4-39(+) cases) had essentially identical V(H)/D/J(H) use and similar HCDR3 lengths but less conserved N-regions. Analysis in all 6 of these subgroups showed restriction in V(L) gene use, whereas no association between V(H) and V(L) usage was found in cases without HCDR3 similarities. Altogether, structurally similar HCDR3s associated with preferential V(L) gene usage implies selection of BCRs, especially in subsets showing high HCDR3 similarities, thus pointing to restricted antigen recognition sites and possibly involvement of specific antigens in CLL development.
我们最近利用免疫球蛋白重链可变区(V(H))基因V(H)3-21鉴定出一个慢性淋巴细胞白血病(CLL)亚组,该亚组具有几乎相同的重链互补决定区3(HCDR3s)以及优先使用的轻链可变区(V(L))基因,这表明在该亚组中识别出了共同的抗原表位。为了进一步探究CLL中的B细胞受体(BCRs),我们对从346例CLL中扩增出的407个V(H)重排进行了V(H)、多样性(D)和连接(J(H))基因使用情况的特征分析,并对HCDR3序列进行了多重比对。这些分析揭示了3个小亚组(2个V(H)1-69组,共7例;以及1个V(H)1-2组,共5例),其HCDR3特征高度受限,包括相同的V(H)/D/J(H)使用情况、HCDR3长度以及共享的N序列,此外还有V(H)3-21组(22例)。此外,另外3组(9例V(H)1-3(+)病例、3例V(H)1-18(+)病例和5例V(H)4-39(+)病例)具有基本相同的V(H)/D/J(H)使用情况和相似的HCDR3长度,但N区域的保守性较低。对所有这6个亚组的分析表明V(L)基因使用存在限制,而在没有HCDR3相似性的病例中未发现V(H)和V(L)使用之间的关联。总之,与优先使用V(L)基因相关的结构相似的HCDR3s意味着BCRs的选择,特别是在显示出高HCDR3相似性的亚组中,从而表明CLL发展中抗原识别位点受限以及可能涉及特定抗原。